Fibrostenotic Crohn's Disease
Immunology·MeSH: Inflammatory Bowel Diseases
Prevalence
17.9 / 100K
Incidence
1.7 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| pali-2108 | PALISADE BIO, INC. (PALI) |
Frequently asked questions
How many drugs are in development for Fibrostenotic Crohn's Disease?
BioSniper tracks 1 drug in development for Fibrostenotic Crohn's Disease across 1 company.
How many clinical trials target Fibrostenotic Crohn's Disease?
There are 3 clinical trials targeting Fibrostenotic Crohn's Disease tracked by BioSniper.
What is the prevalence of Fibrostenotic Crohn's Disease?
The estimated prevalence of Fibrostenotic Crohn's Disease is approximately 17.9 per 100,000 population.
Deep-dive into Fibrostenotic Crohn's Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis